Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance

Ruggero De Maria Marchiano, Micol Eleonora Fiori, Lidia Villanova, Simone Di Franco, Paola Bianca, Giorgio Stassi

Research output: Contribution to journalArticle

114 Citations (Scopus)


In the last decades, the role of the microenvironment in tumor progression and therapeutic outcome has gained increasing attention. Cancer-associated fibroblasts (CAFs) have emerged as key players among stromal cells, owing to their abundance in most solid tumors and their diverse tumor-restraining/promoting roles. The interplay between tumor cells and neighboring CAFs takes place by both paracrine signals (cytokines, exosomes and metabolites) or by the multifaceted functions of the surrounding extracellular matrix. Here, we dissect the most recent identified mechanisms underlying CAF-mediated control of tumor progression and therapy resistance, which include induction of the epithelial-to-mesenchymal transition (EMT), activation of survival pathways or stemness-related programs and metabolic reprogramming in tumor cells. Importantly, the recently unveiled heterogeneity in CAFs claims tailored therapeutic efforts aimed at eradicating the specific subset facilitating tumor progression, therapy resistance and relapse. However, despite the large amount of pre-clinical data, much effort is still needed to translate CAF-directed anti-cancer strategies from the bench to the clinic.
Original languageEnglish
Pages (from-to)70-N/A
JournalMolecular Cancer
Publication statusPublished - 2019


  • Cancer-associated fibroblasts


Dive into the research topics of 'Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance'. Together they form a unique fingerprint.

Cite this